PF-07994525
/ Pfizer
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 24, 2026
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
(clinicaltrials.gov)
- P1 | N=120 | Not yet recruiting | Sponsor: Pfizer
New P1 trial • Hematological Malignancies • Multiple Myeloma • Oncology
June 02, 2026
An Open-Label Study to Evaluate PF-07994525 in Participants With Advanced Cancers
(clinicaltrials.gov)
- P1 | N=120 | Recruiting | Sponsor: Pfizer | Not yet recruiting ➔ Recruiting
Enrollment open • Hematological Malignancies • Multiple Myeloma • Oncology
1 to 2
Of
2
Go to page
1